Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 37 | 2023 | 69 | 12.070 |
Why?
|
| Obesity, Morbid | 36 | 2023 | 105 | 10.290 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2022 | 165 | 5.180 |
Why?
|
| Weight Loss | 20 | 2022 | 127 | 4.240 |
Why?
|
| Bariatric Surgery | 14 | 2023 | 52 | 4.150 |
Why?
|
| Laparoscopy | 29 | 2022 | 188 | 3.680 |
Why?
|
| Postoperative Complications | 13 | 2023 | 928 | 1.920 |
Why?
|
| Insulin Resistance | 6 | 2018 | 50 | 1.890 |
Why?
|
| Obesity | 8 | 2022 | 309 | 1.850 |
Why?
|
| Gastroesophageal Reflux | 12 | 2012 | 27 | 1.570 |
Why?
|
| Middle Aged | 52 | 2022 | 9031 | 1.450 |
Why?
|
| Gastrectomy | 7 | 2023 | 30 | 1.380 |
Why?
|
| Adipose Tissue | 4 | 2018 | 76 | 1.290 |
Why?
|
| Fundoplication | 10 | 2012 | 22 | 1.240 |
Why?
|
| Female | 56 | 2022 | 15269 | 1.240 |
Why?
|
| Humans | 79 | 2023 | 27158 | 1.240 |
Why?
|
| Adult | 41 | 2022 | 7918 | 1.230 |
Why?
|
| Male | 52 | 2022 | 14821 | 1.180 |
Why?
|
| Prospective Studies | 21 | 2022 | 1783 | 1.140 |
Why?
|
| Body Mass Index | 9 | 2020 | 461 | 1.090 |
Why?
|
| Gastroplasty | 6 | 2019 | 27 | 1.080 |
Why?
|
| Insulin | 4 | 2016 | 91 | 1.060 |
Why?
|
| Esophageal Achalasia | 7 | 2015 | 18 | 0.990 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 129 | 0.900 |
Why?
|
| Bibliometrics | 2 | 2021 | 30 | 0.850 |
Why?
|
| General Surgery | 2 | 2021 | 55 | 0.820 |
Why?
|
| Caloric Restriction | 2 | 2014 | 16 | 0.820 |
Why?
|
| Quality of Life | 7 | 2016 | 629 | 0.820 |
Why?
|
| Treatment Outcome | 22 | 2022 | 3525 | 0.810 |
Why?
|
| Biomarkers | 3 | 2020 | 559 | 0.790 |
Why?
|
| Digestive System Surgical Procedures | 6 | 2015 | 24 | 0.770 |
Why?
|
| Adiponectin | 2 | 2012 | 10 | 0.770 |
Why?
|
| Omentum | 2 | 2012 | 7 | 0.770 |
Why?
|
| Follow-Up Studies | 15 | 2022 | 1802 | 0.760 |
Why?
|
| Bone Density | 2 | 2020 | 145 | 0.760 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 32 | 0.710 |
Why?
|
| Esophagus | 3 | 2012 | 63 | 0.700 |
Why?
|
| Case-Control Studies | 9 | 2019 | 589 | 0.700 |
Why?
|
| Weight Gain | 2 | 2021 | 64 | 0.690 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 67 | 0.680 |
Why?
|
| Mental Disorders | 1 | 2022 | 142 | 0.670 |
Why?
|
| Osteoclasts | 1 | 2020 | 22 | 0.660 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 39 | 0.650 |
Why?
|
| Protein Precursors | 1 | 2019 | 20 | 0.650 |
Why?
|
| Fractures, Bone | 1 | 2020 | 73 | 0.630 |
Why?
|
| Neoplasms | 1 | 2022 | 241 | 0.610 |
Why?
|
| Hydroxybutyrates | 1 | 2018 | 7 | 0.590 |
Why?
|
| Retrospective Studies | 15 | 2023 | 3546 | 0.580 |
Why?
|
| Postprandial Period | 3 | 2016 | 7 | 0.570 |
Why?
|
| Aged | 22 | 2022 | 9084 | 0.530 |
Why?
|
| Vascular Diseases | 1 | 2016 | 42 | 0.510 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2016 | 9 | 0.500 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 37 | 0.490 |
Why?
|
| Adipocytes | 2 | 2012 | 22 | 0.490 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 324 | 0.480 |
Why?
|
| Peptide YY | 2 | 2011 | 2 | 0.470 |
Why?
|
| Leptin | 2 | 2011 | 21 | 0.470 |
Why?
|
| Anastomosis, Roux-en-Y | 4 | 2007 | 7 | 0.450 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 5 | 0.440 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 58 | 0.420 |
Why?
|
| Time Factors | 6 | 2016 | 1438 | 0.410 |
Why?
|
| Gastric Acid | 1 | 2012 | 9 | 0.400 |
Why?
|
| Postoperative Period | 5 | 2020 | 334 | 0.390 |
Why?
|
| Nomograms | 1 | 2012 | 6 | 0.390 |
Why?
|
| Subcutaneous Fat | 1 | 2012 | 8 | 0.390 |
Why?
|
| E2F4 Transcription Factor | 1 | 2011 | 2 | 0.380 |
Why?
|
| Appetite | 1 | 2011 | 4 | 0.380 |
Why?
|
| Blood Glucose | 4 | 2014 | 108 | 0.370 |
Why?
|
| Cell Differentiation | 1 | 2012 | 135 | 0.370 |
Why?
|
| Cohort Studies | 5 | 2022 | 1901 | 0.370 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 40 | 0.370 |
Why?
|
| Reoperation | 5 | 2021 | 921 | 0.360 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 87 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 157 | 0.350 |
Why?
|
| Catheter Ablation | 4 | 2004 | 60 | 0.340 |
Why?
|
| Bone and Bones | 2 | 2019 | 117 | 0.290 |
Why?
|
| Risk Factors | 8 | 2021 | 2334 | 0.290 |
Why?
|
| Adolescent | 7 | 2020 | 2179 | 0.290 |
Why?
|
| Body Composition | 2 | 2021 | 69 | 0.290 |
Why?
|
| Deglutition Disorders | 2 | 2007 | 32 | 0.280 |
Why?
|
| United States | 6 | 2022 | 2066 | 0.280 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2007 | 1 | 0.270 |
Why?
|
| Coronary Disease | 1 | 2007 | 51 | 0.270 |
Why?
|
| Young Adult | 6 | 2020 | 2026 | 0.260 |
Why?
|
| Incidence | 2 | 2022 | 763 | 0.260 |
Why?
|
| Esophagectomy | 1 | 2006 | 23 | 0.260 |
Why?
|
| Laparotomy | 2 | 2021 | 19 | 0.250 |
Why?
|
| Cholecystitis | 3 | 2023 | 9 | 0.240 |
Why?
|
| Esophagoscopy | 5 | 2005 | 15 | 0.240 |
Why?
|
| Hypoglycemia | 2 | 2016 | 13 | 0.240 |
Why?
|
| Esophageal Neoplasms | 2 | 2005 | 50 | 0.230 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 316 | 0.230 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2012 | 11 | 0.220 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 13 | 0.220 |
Why?
|
| Prognosis | 5 | 2020 | 804 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 86 | 0.220 |
Why?
|
| Absorptiometry, Photon | 2 | 2014 | 84 | 0.210 |
Why?
|
| Transcription Factors | 1 | 2004 | 166 | 0.210 |
Why?
|
| Preoperative Period | 3 | 2019 | 82 | 0.210 |
Why?
|
| Gallstones | 1 | 2023 | 7 | 0.210 |
Why?
|
| Apoptosis | 1 | 2004 | 210 | 0.210 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 140 | 0.210 |
Why?
|
| Patient Readmission | 2 | 2021 | 130 | 0.200 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 275 | 0.200 |
Why?
|
| Energy Metabolism | 2 | 2021 | 53 | 0.200 |
Why?
|
| Fibronectins | 1 | 2022 | 19 | 0.190 |
Why?
|
| Remission Induction | 2 | 2016 | 90 | 0.190 |
Why?
|
| Metabolome | 1 | 2021 | 14 | 0.190 |
Why?
|
| Preoperative Care | 2 | 2016 | 119 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 96 | 0.190 |
Why?
|
| Comorbidity | 2 | 2021 | 488 | 0.180 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 8 | 0.180 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 216 | 0.170 |
Why?
|
| Cells, Cultured | 2 | 2012 | 524 | 0.170 |
Why?
|
| Cefoxitin | 1 | 2020 | 3 | 0.170 |
Why?
|
| Metronidazole | 1 | 2020 | 5 | 0.170 |
Why?
|
| Levofloxacin | 1 | 2020 | 3 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2021 | 141 | 0.170 |
Why?
|
| Linear Models | 2 | 2014 | 246 | 0.170 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 29 | 0.170 |
Why?
|
| Medicare | 1 | 2021 | 123 | 0.170 |
Why?
|
| Morbidity | 1 | 2020 | 54 | 0.160 |
Why?
|
| Risk Assessment | 3 | 2014 | 628 | 0.160 |
Why?
|
| Analysis of Variance | 2 | 2019 | 256 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 903 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 261 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 291 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2020 | 78 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 31 | 0.140 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 2 | 0.140 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 3 | 0.140 |
Why?
|
| Kidney | 1 | 2018 | 152 | 0.140 |
Why?
|
| Length of Stay | 2 | 2017 | 319 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 159 | 0.140 |
Why?
|
| Gene Expression | 1 | 2017 | 200 | 0.130 |
Why?
|
| Patient Satisfaction | 4 | 2007 | 320 | 0.130 |
Why?
|
| Esophagogastric Junction | 3 | 2004 | 13 | 0.130 |
Why?
|
| Recurrence | 1 | 2016 | 309 | 0.120 |
Why?
|
| Surveys and Questionnaires | 4 | 2007 | 1154 | 0.120 |
Why?
|
| Gastroscopy | 2 | 2004 | 9 | 0.110 |
Why?
|
| Mental Health | 1 | 2016 | 109 | 0.110 |
Why?
|
| Gastrointestinal Hormones | 1 | 2014 | 1 | 0.110 |
Why?
|
| Amino Acids | 1 | 2014 | 20 | 0.110 |
Why?
|
| Lipids | 1 | 2014 | 50 | 0.110 |
Why?
|
| Biliopancreatic Diversion | 1 | 2013 | 1 | 0.100 |
Why?
|
| Duodenum | 1 | 2013 | 5 | 0.100 |
Why?
|
| Choline | 1 | 2013 | 4 | 0.100 |
Why?
|
| Carbon | 1 | 2013 | 9 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2014 | 195 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2013 | 26 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 16 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 41 | 0.100 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2011 | 1 | 0.100 |
Why?
|
| Reference Values | 1 | 2012 | 185 | 0.100 |
Why?
|
| Ghrelin | 1 | 2011 | 2 | 0.100 |
Why?
|
| Neuropeptide Y | 1 | 2011 | 5 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 92 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 270 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 596 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2011 | 13 | 0.090 |
Why?
|
| Fasting | 1 | 2011 | 21 | 0.090 |
Why?
|
| Exercise | 1 | 2016 | 452 | 0.090 |
Why?
|
| Postoperative Care | 1 | 2012 | 135 | 0.090 |
Why?
|
| Food | 1 | 2011 | 37 | 0.090 |
Why?
|
| Chi-Square Distribution | 3 | 2007 | 138 | 0.090 |
Why?
|
| Suture Techniques | 3 | 2007 | 156 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2012 | 310 | 0.090 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 2015 | 20 | 0.090 |
Why?
|
| Aging | 2 | 2018 | 1550 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 272 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2009 | 23 | 0.080 |
Why?
|
| Muscle, Smooth | 2 | 2006 | 12 | 0.080 |
Why?
|
| Medicaid | 1 | 2009 | 36 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4831 | 0.080 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 19 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 119 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2007 | 23 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 30 | 0.070 |
Why?
|
| Vitamin D | 1 | 2007 | 38 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 2006 | 25 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2007 | 60 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 162 | 0.060 |
Why?
|
| Tennessee | 1 | 2006 | 6 | 0.060 |
Why?
|
| Markov Chains | 1 | 2006 | 33 | 0.060 |
Why?
|
| Gastroenterostomy | 1 | 2005 | 1 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2006 | 22 | 0.060 |
Why?
|
| Operative Time | 2 | 2017 | 92 | 0.060 |
Why?
|
| Body Weight | 1 | 2006 | 135 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 38 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2006 | 47 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2006 | 87 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 37 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 126 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2006 | 73 | 0.060 |
Why?
|
| Endoscopy | 1 | 2007 | 182 | 0.060 |
Why?
|
| Equipment Design | 4 | 2006 | 136 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 303 | 0.060 |
Why?
|
| Choledocholithiasis | 1 | 2004 | 1 | 0.060 |
Why?
|
| Cholecystolithiasis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2004 | 3 | 0.060 |
Why?
|
| Diet | 1 | 2006 | 219 | 0.060 |
Why?
|
| Logistic Models | 1 | 2005 | 397 | 0.060 |
Why?
|
| COS Cells | 1 | 2004 | 39 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 82 | 0.060 |
Why?
|
| Laryngitis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Hyperthermia, Induced | 1 | 2004 | 7 | 0.060 |
Why?
|
| Laryngostenosis | 1 | 2004 | 5 | 0.060 |
Why?
|
| Calcium | 1 | 2007 | 369 | 0.050 |
Why?
|
| Animals | 2 | 2018 | 3625 | 0.050 |
Why?
|
| Motor Activity | 1 | 2006 | 321 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 264 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 4 | 0.050 |
Why?
|
| Bile | 2 | 1993 | 5 | 0.050 |
Why?
|
| Abdomen | 1 | 2022 | 7 | 0.050 |
Why?
|
| Pancreas | 1 | 2022 | 32 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2022 | 31 | 0.050 |
Why?
|
| Standard of Care | 1 | 2021 | 13 | 0.050 |
Why?
|
| Peritoneum | 1 | 2021 | 16 | 0.050 |
Why?
|
| Hydrocephalus | 1 | 2021 | 16 | 0.040 |
Why?
|
| Postmenopause | 1 | 2019 | 57 | 0.040 |
Why?
|
| Surgical Wound Infection | 2 | 2006 | 87 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 350 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 32 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 13 | 0.040 |
Why?
|
| Anemia | 1 | 2017 | 34 | 0.040 |
Why?
|
| Colonic Pseudo-Obstruction | 1 | 1997 | 1 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 369 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 148 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2006 | 331 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 49 | 0.030 |
Why?
|
| Sigmoid Diseases | 1 | 1996 | 1 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 1996 | 2 | 0.030 |
Why?
|
| Abdominal Abscess | 1 | 1996 | 2 | 0.030 |
Why?
|
| Diverticulitis, Colonic | 1 | 1996 | 3 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 151 | 0.030 |
Why?
|
| Jejunum | 2 | 2006 | 10 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 466 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 193 | 0.030 |
Why?
|
| Diet Therapy | 1 | 2016 | 11 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 131 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 775 | 0.030 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 2 | 0.030 |
Why?
|
| Appendectomy | 1 | 2015 | 14 | 0.030 |
Why?
|
| Manometry | 2 | 2005 | 16 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 31 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 1993 | 51 | 0.030 |
Why?
|
| Conversion to Open Surgery | 1 | 2013 | 3 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 200 | 0.020 |
Why?
|
| Esthetics | 1 | 2012 | 13 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1992 | 10 | 0.020 |
Why?
|
| Learning Curve | 1 | 2012 | 19 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 344 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 148 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1990 | 29 | 0.020 |
Why?
|
| Computers | 1 | 1990 | 17 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 197 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 485 | 0.020 |
Why?
|
| Probability | 1 | 2007 | 86 | 0.020 |
Why?
|
| Gastric Acidity Determination | 1 | 2006 | 2 | 0.020 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2006 | 2 | 0.020 |
Why?
|
| Mesocolon | 1 | 2006 | 1 | 0.020 |
Why?
|
| Peritoneal Diseases | 1 | 2006 | 3 | 0.020 |
Why?
|
| Jejunal Diseases | 1 | 2006 | 3 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 90 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 6 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2006 | 8 | 0.020 |
Why?
|
| Pneumonia, Aspiration | 1 | 2006 | 8 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2006 | 12 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2006 | 101 | 0.020 |
Why?
|
| Hernia | 1 | 2006 | 9 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2006 | 11 | 0.020 |
Why?
|
| Needles | 1 | 2006 | 19 | 0.020 |
Why?
|
| Marital Status | 1 | 2006 | 10 | 0.020 |
Why?
|
| Peptide Hormones | 1 | 2006 | 3 | 0.020 |
Why?
|
| Energy Intake | 1 | 2006 | 83 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2005 | 22 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 30 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 344 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 66 | 0.010 |
Why?
|
| Neuromuscular Agents | 1 | 2005 | 4 | 0.010 |
Why?
|
| Esophageal Stenosis | 1 | 2005 | 3 | 0.010 |
Why?
|
| Botulinum Toxins | 1 | 2005 | 8 | 0.010 |
Why?
|
| Proton Pump Inhibitors | 1 | 2004 | 11 | 0.010 |
Why?
|
| Choledochostomy | 1 | 2004 | 1 | 0.010 |
Why?
|
| Common Bile Duct | 1 | 2004 | 1 | 0.010 |
Why?
|
| Cholangiography | 1 | 2004 | 7 | 0.010 |
Why?
|
| Gastroscopes | 1 | 2004 | 1 | 0.010 |
Why?
|
| Esophagoscopes | 1 | 2004 | 1 | 0.010 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2004 | 2 | 0.010 |
Why?
|
| Polyvinyls | 1 | 2004 | 3 | 0.010 |
Why?
|
| Polymethyl Methacrylate | 1 | 2004 | 10 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2004 | 70 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 127 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 892 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 673 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 407 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 2003 | 8 | 0.010 |
Why?
|
| Gastrointestinal Transit | 1 | 2003 | 12 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 478 | 0.010 |
Why?
|
| Acute Disease | 2 | 1993 | 177 | 0.010 |
Why?
|
| Colostomy | 1 | 1996 | 2 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1996 | 29 | 0.010 |
Why?
|
| Drainage | 1 | 1996 | 44 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 1997 | 127 | 0.010 |
Why?
|
| Radiography | 1 | 1997 | 617 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1993 | 9 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1992 | 6 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 1992 | 6 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1990 | 9 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1990 | 18 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1992 | 425 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1990 | 347 | 0.000 |
Why?
|